Efficacy, Safety and Tolerability of XBD173 in Patients With Generalized Anxiety Disorder
Public ClinicalTrials.gov record NCT00108836. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will test the efficacy, safety and tolerability of XBD173 in the treatment of generalized anxiety disorder in patients.
Study identification
- NCT ID
- NCT00108836
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 400 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2005
- Primary completion
- Not listed
- Completion
- Apr 30, 2006
- Last update posted
- May 19, 2010
2005 – 2006
United States locations
- U.S. sites
- 16
- U.S. states
- 8
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site | Anaheim | California | 92801 | — |
| Investigational Site | Los Angeles | California | 90024 | — |
| Investigational Site | Newport Beach | California | 92660 | — |
| Investigational Site | Redlands | California | 92374 | — |
| Investigational Site | San Diego | California | 92108 | — |
| Investigational Site | Fort Meyers | Florida | 33712 | — |
| Investigational Site | St. Petersburg | Florida | 33702 | — |
| Investigational Site | West Palm Beach | Florida | 33407 | — |
| Investigational Site | Atlanta | Georgia | 30308 | — |
| Investigational Site | Hoffman Estates | Illinois | 60194 | — |
| Investigational Site | Oak Brook | Illinois | 60523 | — |
| Investigational Site | Overland Park | Kansas | 66211 | — |
| Investigational Site | Dayton | Ohio | 45408 | — |
| Investigational Site | Portland | Oregon | 97239 | — |
| Investigational Site | Madison | Tennessee | 37115 | — |
| Investigational Site | Memphis | Tennessee | 38119 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00108836, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 19, 2010 · Synced Sep 13, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00108836 live on ClinicalTrials.gov.